PubRank

V Wynn

Author PubWeight™ 112.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966 5.48
2 Cardiologists rebuked. Lancet 1994 3.85
3 Potassium chloride and intestinal ulceration. Lancet 1965 3.42
4 Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1979 2.08
5 Insulin resistance and cigarette smoking. Lancet 1992 1.98
6 The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 1966 1.85
7 Divergent thinking: strategies and executive involvement in generating novel uses for familiar objects. Br J Psychol 2007 1.75
8 A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet 1985 1.64
9 Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Atherosclerosis 1976 1.58
10 Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976 1.52
11 Counting on working memory in arithmetic problem solving. Mem Cognit 1994 1.51
12 Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1969 1.49
13 A fundamental defect of adrenocortical control in Cushing's disease. J Endocrinol 1968 1.46
14 Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol (Oxf) 1979 1.46
15 The anabolic steroids. Practitioner 1968 1.39
16 Vitamins and oral contraceptive use. Lancet 1975 1.35
17 Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987 1.33
18 Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis 1987 1.32
19 Serum-lipids in women on oral contraceptives. Lancet 1971 1.29
20 The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 1982 1.27
21 Endocrine function in patients with untreated chromophobe adenomas. Q J Med 1967 1.13
22 Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives. J Clin Pathol 1983 1.09
23 Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia. Hum Genet 1985 1.08
24 The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990 1.08
25 Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism. Am J Obstet Gynecol 1982 1.05
26 The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 1993 1.05
27 Visual similarity effects in immediate verbal serial recall. Q J Exp Psychol A 2000 1.04
28 Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels. Br Med J 1970 1.02
29 Working memory and strategies in syllogistic-reasoning tasks. Mem Cognit 1993 1.01
30 The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism. Eur J Clin Invest 1974 1.01
31 Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res 1973 1.01
32 Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992 1.00
33 The role of memory in the Tower of London task. Memory 1999 1.00
34 Plasma free fatty acid and triglyceride transport kinetics in man. Clin Sci Mol Med 1974 0.99
35 Reproducibility of oral glucose tolerance data in normal and mildly diabetic subjects. Clin Endocrinol (Oxf) 1973 0.99
36 Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993 0.98
37 Effect of pyridoxine hydrochloride (vitamin B 6 ) upon depression associated with oral contraception. Lancet 1973 0.98
38 Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metabolism 1968 0.98
39 Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992 0.97
40 Metabolic effects of danazol. J Int Med Res 1977 0.96
41 Group aggregates and individual reliability: the case of verbal short-term memory. Mem Cognit 1996 0.95
42 Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy. Lancet 1969 0.93
43 Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathy. Electroencephalogr Clin Neurophysiol 1986 0.93
44 The evaluation of sodium valproate in the treatment of Nelson's syndrome. J Clin Endocrinol Metab 1983 0.93
45 Oral and intravenous suppression tests in the diagnosis of Cushing's syndrome. J Endocrinol 1965 0.93
46 Metabolic effects of anabolic steroids. Br J Sports Med 1975 0.91
47 Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism 1994 0.90
48 Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease. Q J Med 1968 0.90
49 Variation in serum lipid and lipoprotein levels associated with changes in smoking behaviour in non-obese Caucasian males. Atherosclerosis 1985 0.90
50 Parenteral administration of 6-alpha-methylprednisolone-21-acetate. II. Absorption and duration of effect. Ann Phys Med 1967 0.90
51 Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab 1992 0.87
52 Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity. Eur J Clin Invest 1977 0.87
53 Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes 1969 0.87
54 Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin). Diabetologia 1974 0.87
55 The assessment of hypothalamic-pituitary-adrenocortical function in man. Proc R Soc Med 1967 0.86
56 Diurnal variation on oral glucose tolerance: insulin and growth hormone changes with special reference to women taking oral contraceptives. Diabetologia 1973 0.86
57 Effect of posture on the plasma cholesterol level. Br Med J 1966 0.86
58 The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Eur J Clin Invest 1974 0.85
59 Clofibrate and hyperlipidaemia. Lancet 1980 0.85
60 The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia. Diabetologia 1976 0.85
61 Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception 1995 0.84
62 The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia. Atherosclerosis 1977 0.83
63 The influence on oral contraceptive formulation on carbohydrate and lipid metabolism. J Pharmacother 1980 0.83
64 The role of calcium in insulin action. V. Importance of cyclic guanosine 3':5' monophosphate and calcium ions in insulin stimulation of lipoprotein lipase activity and protein synthesis in adipose tissue. Horm Metab Res 1978 0.83
65 Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol 1992 0.81
66 Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Arterioscler Thromb 1992 0.81
67 Studies of carbohydrate and lipid metabolism in women developing hypertension on oral contraceptives. Br Med J 1973 0.81
68 The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism. Clin Endocrinol (Oxf) 1984 0.81
69 Effects of oral contraceptives on carbohydrate metabolism. J Reprod Med 1986 0.81
70 Late acute rejection occurring in liver allograft recipients. Can J Gastroenterol 1996 0.80
71 Coronary heart disease risk markers in users of low-dose oral contraceptives. J Reprod Med 1991 0.80
72 Pancreatic islet cell tumour with watery diarrhoea and hypokalaemia. Gut 1970 0.80
73 Blood pyruvate and lactate levels during oral and intravenous glucose tolerance tests in diabetes mellitus. Clin Sci 1970 0.80
74 Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom. Metabolism 1996 0.80
75 Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med 1987 0.80
76 The effects of growth hormone on plasma glucose, NEFA, insulin and blood pyruvate levels during intravenous glucose tolerance tests. J Endocrinol 1969 0.79
77 Lipid and carbohydrate metabolism in premenopausal women given subdermal estradiol implants. Horm Metab Res 1991 0.79
78 The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist. J Endocrinol Invest 1988 0.78
79 Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson's syndrome. Lancet 1981 0.78
80 Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol 1988 0.78
81 Inverse relationship between serum Lp(a) levels and first-phase insulin secretion. Diabetes 1992 0.78
82 Effect of methandienone on free fatty acid and triglyceride turnover in normal females. Horm Metab Res 1973 0.77
83 Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta 1982 0.77
84 Corticotrophin, cortisol, prolactin and growth hormone responses to insulin-induced hypoglycaemia in normal subjects given sodium valproate. Clin Endocrinol (Oxf) 1985 0.77
85 Influence of oral contraceptives, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism. Lancet 1976 0.77
86 Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol). Clin Sci (Lond) 1986 0.77
87 Rising cholesterol levels in children with familial hypercholesterolaemia. Biomed Pharmacother 1990 0.76
88 Case studies in working memory: a case for single cases? Cortex 1991 0.76
89 Clinical and metabolic considerations of long-term oral contraceptive use. Am J Obstet Gynecol 1992 0.76
90 The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters. J Endocrinol Invest 1987 0.76
91 Letter: Vitamin B 6, depression, and oral contraception. Lancet 1974 0.76
92 A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathy. Adv Exp Med Biol 1984 0.76
93 Some effects of oral contraceptives on serum lipid and lipoprotein levels. Lancet 1966 0.76
94 Oral contraceptives and diabetes mellitus. BMJ 1990 0.75
95 Thiazide diuretics, beta-blockers, and coronary heart disease. Lancet 1990 0.75
96 The effects of triiodothyronine on energy expenditure, nitrogen balance and rates of weight and fat loss in obese patients during prolonged caloric restriction. Int J Obes 1985 0.75
97 Cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1992 0.75
98 Role of glucose and insulin resistance in development of type 2 diabetes mellitus. Lancet 1992 0.75
99 Potassium chloride and bowel ulceration. Br Med J 1965 0.75
100 Scare over oral contraceptives. Committee's action will undermine further research and development. BMJ 1995 0.75
101 The relation of growth hormone to altered carbohydrate metabolism in women taking oral contraceptives. J Clin Pathol 1972 0.75
102 Congenital adrenal hyperplasia and XYY hypogonadism. J R Soc Med 1985 0.75
103 Observations on some effects of L-triiodothyronine on carbohydrate and lipid metabolism in man. J Clin Pathol 1969 0.75
104 Lipokinetic studies with gemfibrozil (CI-719). Proc R Soc Med 1976 0.75
105 HDL as an independent risk factor in British men (and women) BMJ 1989 0.75
106 Prescribing oral contraceptives. Nature 1996 0.75
107 Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives. Br J Clin Pharmacol 1989 0.75
108 Oral contraceptives and glucose tolerance. Lancet 1969 0.75
109 Does the new progestagen desogestrel have metabolic advantages? Lancet 1984 0.75
110 Low-density lipoprotein metabolism by cultured human fibroblasts: relationship with aging and atherosclerosis. Gerontology 1984 0.75
111 Creatinine excretion. Hum Nutr Clin Nutr 1985 0.75
112 An apparently anomalous relationship between insulin and C-peptide concentrations in their initial response to intravenous glucose. Metabolism 1992 0.75
113 Methodological issues in the application of the minimal model: effects of glucose dose, basal glucose concentration, test duration and modelling constraint. Diabetes Res 1994 0.75
114 Danazol induces resistance to both insulin and glucagon in young women. Clin Sci (Lond) 1992 0.75
115 The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease. Clin Endocrinol (Oxf) 1986 0.75
116 Low-dose oral contraceptives and carbohydrate metabolism. Am J Obstet Gynecol 1990 0.75
117 Possible iatrogenic hypothyroidism. Lancet 1981 0.75
118 Observations on some extra-adrenal effects of corticotropin on carbohydrate and lipid metabolism in man. Metabolism 1965 0.75
119 Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids. Eur J Clin Invest 1975 0.75
120 Effect of high and low-carbohydrate diets on nitrogen balance during calorie restriction in obese subjects. Int J Obes 1982 0.75
121 Relationships among critical thinking skills, academic achievement, and misconceptions about psychology. Psychol Rep 1992 0.75
122 Value of computed tomography of the abdomen and chest in investigation of Cushing's syndrome. Br Med J (Clin Res Ed) 1982 0.75
123 Insulin resistance--modelling studies. Eur J Epidemiol 1992 0.75
124 Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Cardiovasc Drugs Ther 1992 0.75
125 Tryptophan, depression and steroidal contraception. J Steroid Biochem 1975 0.75
126 Low density lipoprotein metabolism by cultured skin fibroblasts from atherosclerotic patients. Atherosclerosis 1982 0.75
127 Electrocardiographic abnormalities in women taking oral contraceptives. Lancet 1977 0.75
128 Oral contraceptives and breast cancer rates. Lancet 1984 0.75
129 Method for estimating rate of fat loss during treatment of obesity by calorie restriction. Lancet 1985 0.75
130 [Influence of progestins on adverse effects of oral contraceptives]. Contracept Fertil Sex (Paris) 1985 0.75
131 The effects of gonadal hormones and contraceptive steroids on serum lipids. Clin Sci 1971 0.75
132 Whither the latest insulins? Lancet 1982 0.75
133 High density lipoprotein subfraction cholesterol in hypertriglyceridaemia. Atherosclerosis 1982 0.75
134 Changes in bone and muscle constituents during dieting for obesity. Clin Sci (Lond) 1986 0.75
135 Reduction in resting energy expenditure in relation to lean tissue loss in obese subjects during prolonged dieting. Ann Nutr Metab 1987 0.75
136 Venous blood arterialization and parameters from the minimal models of glucose disappearance and post-hepatic insulin delivery. Clin Sci (Lond) 1993 0.75
137 Oral contraceptives and metabolic risk markers for coronary heart disease. Int J Fertil 1991 0.75
138 Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism. Clin Endocrinol (Oxf) 1986 0.75
139 Cardiovascular effects and progestins in oral contraceptives. Am J Obstet Gynecol 1982 0.75
140 Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively. Contraception 1989 0.75
141 The effects of a progestogen, megestrol acetate, on carbohydrate and lipid metabolism. J Obstet Gynaecol Br Commonw 1972 0.75
142 Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics. Diabetologia 1987 0.75
143 Progestagens and high-density lipoproteins. Lancet 1984 0.75
144 Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study. Ann Acad Med Singapore 1982 0.75
145 The role of left-right symmetry in the encodement of spatial orientations. Br J Psychol 2000 0.75
146 Oxygen consumption of obese and anorectic patients. Proc Nutr Soc 1975 0.75
147 Plasma lipid risk factors in oophorectomized women. Br J Obstet Gynaecol 1989 0.75
148 Diurnal patterns of plasma glucagon and insulin in normal and diabetic subjects. Horm Metab Res 1978 0.75
149 Comparison of tests of hypothalamo-pituitary-adrenocortical function in pituitary disease. J Endocrinol 1970 0.75